ABCIXIMAB: a new antiaggregant used in angioplasty. - Wikidata - wikimedia - TriplyDB

ABCIXIMAB: a new antiaggregant used in angioplasty.

ABCIXIMAB: a new antiaggregant used in angioplasty.

http://www.wikidata.org/entity/Q33497071

about

Engineered IgG1-Fc--one fragment to bind them all Atherothrombosis in diabetes--its evolution and management.Future innovations in anti-platelet therapies.Pharmacokinetics, pharmacodynamics and physiologically-based pharmacokinetic modelling of monoclonal antibodies.

P2860

Q26766715-1CAF9D3F-47D2-4A19-B158-CE80A6010F7C Q34164126-58A905BE-9C01-4C08-A7D7-E699673598A5 Q36753593-9DA8F3AB-2127-4022-9A3F-9A6295B95C51 Q38072598-A7C47A48-D6FC-4E77-913D-570A86FB6403

P2860

ABCIXIMAB: a new antiaggregant used in angioplasty.

http://www.wikidata.org/entity/Q33497071

description

1996 nî lūn-bûn

@nan

1996 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի մարտին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

ABCIXIMAB: a new antiaggregant used in angioplasty.

@ast

ABCIXIMAB: a new antiaggregant used in angioplasty.

@en

type

label

ABCIXIMAB: a new antiaggregant used in angioplasty.

@ast

ABCIXIMAB: a new antiaggregant used in angioplasty.

@en

prefLabel

ABCIXIMAB: a new antiaggregant used in angioplasty.

@ast

ABCIXIMAB: a new antiaggregant used in angioplasty.

@en

P1433

Q33497071-84C1C1E8-1E13-450B-905A-45D1EF29699A

P1476

Q33497071-732B986F-7243-4F06-87AB-1C40F43015F5

P2093

Q33497071-128550CC-E10D-49C3-8B86-C053A2AD9F55

Q33497071-AC488BD9-55A8-4D32-8FEF-178834934320

P2860

Q33497071-0822BF85-81AA-4593-AF41-515FA431E4D0

Q33497071-37F9B8E8-23A1-45FE-B066-3925650CECBB

Q33497071-3B44DC51-09D5-4985-983A-60700A9845C0

Q33497071-4F39D4B8-A315-4E61-A5A1-13EC56674D74

Q33497071-5ED7A924-5021-45F0-8A6E-5DC3F0E2AE70

Q33497071-63E65EA9-9749-4232-A87A-8587E207F05E

Q33497071-6F71FB5C-99BB-488D-AA8C-3A9AB504742D

Q33497071-8CA1106B-3DFF-48A3-8131-442027B15CC7

Q33497071-C5ACF593-38AB-473D-9D47-BA20375DB4E0

Q33497071-E1FF4A7E-8A68-4376-9DE0-2CDFDFDD6377

P304

Q33497071-2DB57024-02F7-42A5-A54A-4ECEAB7CBB72

P31

Q33497071-BE337015-1991-428A-8419-8A3AA7AE327A

P356

Q33497071-467E5016-2BAF-4B47-BF88-0A4C57991DA5

P407

Q33497071-5901DC72-95B7-4F57-913A-DC2792B2B042

P433

Q33497071-DDDCFB5B-B53A-4964-A286-08FC6DB3C2FA

P478

Q33497071-03D8952D-0806-4726-9FF6-E56E6E2C4AEE

P577

Q33497071-3F81D460-4D89-4321-84DE-2DFE39331227

P698

Q33497071-F0CE0BA8-A6DD-43C6-B1E0-2DFCD4AE7969

P356

106002809603000309

P1433

Annals of Pharmacotherapy

P1476

ABCIXIMAB: a new antiaggregant used in angioplasty.

@en

P2093

T B Genetta

http://www.w3.org/2001/XMLSchema#string

V F Mauro

http://www.w3.org/2001/XMLSchema#string

P2860

Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.

Platelet surface IgG in patients receiving infusions of Fab fragments of a chimaeric monoclonal antibody to glycoprotein IIb-IIIa.

Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 Pilot Study.

Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris.

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty.

A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex

The use of antibodies in clinical cardiology.

Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs.

Monoclonal antibodies to platelet glycoprotein IIb/IIIa as antithrombotic agents.

Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.

P304

251-257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/106002809603000309

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

1996-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8833561

http://www.w3.org/2001/XMLSchema#string